Mircera

In the US, MIRCERA (epoetin beta-methoxy polyethylene glycol systemic) is a member of the drug class recombinant human erythropoietins and is used to treat Anemia Associated with Chronic Renal Failure.

US matches:

• Mircera

UK matches:

• Mircera solution for injection in pre-filled syringe (SPC)

Ingredient matches for MIRCERA

Epoetin Beta-Methoxy Polyethylene Glycol

Methoxy polyethylene glycol-epoetin beta is reported as an ingredient of MIRCERA in the following countries:

• Australia


• Belgium


• Croatia (Hrvatska)


• Denmark


• France


• Germany


• Greece


• Hungary


• Ireland


• Netherlands


• Norway


• Slovakia


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.